Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Automated Cyclosporine Immunoassay is Simple and Reliable

By HospiMedica staff writers
Posted on 28 Aug 2007
A highly specific automated immunoassay for cyclosporine has been developed for routine use.

The cyclosporine assay is integrated onto a random access immunoassay analyzer, the Advia Centaur system. More...
This reduces the need for multiple analyzers in the lab and saves operational and maintenance time for lab professionals. Engineered to provide "always ready” automation with STAT availability for rapid turnaround, the Advia Centaur does not require operator intervention for repeat requirements.

Introduced by Siemens Medical Solutions Diagnostics (Tarrytown, NY, USA), the Advia Centaur cyclosporine assay allows laboratory professionals to mainstream testing into routine workflow with a simplified extraction process and fully automated processing yielding an 18-minute turnaround time. The Advia Centaur assay's expansive linear range reduces the need for dilutions, reducing the time required for testing and the associated cost. The system features one-tube processing, thereby reducing the need for labor-intensive pipetting, and deliver hundreds of test results per hour. Fully prepared reagents are available to laboratory professionals in a ReadyPack format.

The cyclosporine assay system provides lab professionals with reliable results and physicians with the information they need to optimize patient management. Engineered to provide "always ready” automation with STAT availability for rapid turnaround, the Advia Centaur does not require operator intervention for repeat requirements.

"The ADVIA Centaur Cyclosporine assay shows excellent correlation with the gold standard tandem mass spectrometric method,” said Steven J. Soldin, Ph.D., director, bioanalytical core laboratory, Georgetown University (Washington, DC, USA) and the clinical chemistry laboratories at Children's National Medical Center (Washington, DC, USA). "This method has very good reproducibility and a wide linear range that can accommodate both C0 and C2 testing protocols. In addition, this new cyclosporine assay has little metabolite cross-reactivity.”

"The cyclosporine assay marks Siemens Diagnostics' entry into immunosuppressant drug monitoring, a critical area of healthcare,” said Joe Bernardo, senior vice president, Central Lab Testing, Siemens Medical Solutions Diagnostics. "The release of the cyclosporine assay is an example of how Siemens is utilizing its expertise and resources to expand an already comprehensive, disease focused menu.”


Related Links:
Siemens Medical Solutions Diagnostics
Georgetown University
Children's National Medical Center

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.